(PALO ALTO, Calif.) — CellBio Scientific, a premier provider of life science tools, research services, and clinical solutions, has announced the appointment of Edwin Haghnazari, PhD, MBA, as Chief Commercial Officer (CCO). In this role, Dr. Haghnazari will lead all commercial operations, including sales, marketing, technical and customer support, and international distribution, as the company continues to expand its presence across the life sciences and drug discovery markets.
CellBio Scientific accelerates biomedical discovery and enables innovation from foundational research to clinical applications. Its integrated platform spans biospecimens, molecular tools, extracellular vesicle technologies, gene delivery systems, and preclinical and clinical pathology services. With an unwavering commitment to scientific rigor and quality, CellBio serves as a trusted partner to researchers, biopharma, and clinicians, empowering breakthroughs that advance human health.
Haghnazari brings more than 20 years of leadership experience in R&D, product development, marketing, scientific support, sales, and business development. A seasoned life sciences executive, he combines deep scientific expertise with strong commercial and strategic acumen. His previous roles at Eurofins Discovery, The Jackson Laboratory, and Charnwood Discovery have spanned the entire preclinical and translational value chain — from target identification through IND-enabling studies and clinical support — advancing scientific innovation and commercial success.
“Edwin brings an exceptional combination of scientific insight, commercial leadership, and global perspective,” said Charles Miller, CEO of CellBio Scientific. “He has a unique ability to align complex science with customer needs, foster meaningful partnerships, and inspire teams to perform at their best. As CellBio continues to scale, his leadership will be instrumental in deepening our market impact and delivering even greater value to our global partners.”
Dr. Haghnazari’s leadership philosophy centers on collaboration, clarity, and long-term relationship building. Throughout his career, he has built high-performing teams, developed customer-centric strategies, and driven measurable growth through innovation and partnership.
“I’m honored to join CellBio Scientific at such a pivotal point in its evolution,” said Haghnazari. “CellBio’s scientific depth, integrated platform, and unwavering focus on quality align perfectly with my passion for enabling discoveries that improve patient lives. I’m excited to work with our talented teams and global customers to accelerate progress from research to clinical applications.”
Dr. Haghnazari earned his PhD in Biochemistry and Molecular Biology, with a designated emphasis in Biotechnology, from the University of California, Davis, and an Executive MBA with honors from Santa Clara University’s Leavey School of Business.
